07.04.2016 • NewsDede WillamsK+Swastewater

Short-time Working Ends at K+S

Improved water flow in the river Werra will allow German minerals producer K+S to lift short-time working at the plant in the town of Werra, the company has announced. Production will also resume at the Hattorf, Germany, site this week.

The short-time working plan implemented on Apr. 1 affected some 650 employees at the Hattorf and Wintershall and around 300 employees at Unterbreizbach and Merkers.

As it was also possible to empty the process wastewater basins, production water can now be discharged directly once again, so nothing prohibits operating potash production capacity at full run, K+S said. If conditions worsen, shorter hours may have to be “briefly reintroduced at any time.

Although the company is “happy that we’ve been able to end the unavoidable introduction of short-time working after just a few days,” plant manager Roland Keidel said receiving a wastewater injection permit of sufficient scope as soon as possible remains essential.

K+S has been in a protracted discourse with and among the German federal states over injection of saline wastewater into the soil to relieve the burden on the river.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.